NCT04489121View on ClinicalTrials.gov

The Efficacy of Preseasonal Omalizumab Treatment

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 28, 2020

Primary Completion Date

September 26, 2020

Study Completion Date

October 1, 2020

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

Omalizumab

For patients in the Omalizumab group, subcutaneous injections of Omalizumab based on the specific participant's weight and serum total IgE was performed 2 weeks prior the anticipated pollen season.

Trial Locations (1)

100730

Beijing Tongren Hospital, Beijing

All Listed Sponsors
lead

Beijing Tongren Hospital

OTHER

NCT04489121 - The Efficacy of Preseasonal Omalizumab Treatment | Biotech Hunter | Biotech Hunter